Literature DB >> 20427357

Population-based cancer registries in Spain and their role in cancer control.

C Navarro1, C Martos, E Ardanaz, J Galceran, I Izarzugaza, R Peris-Bonet, C Martínez.   

Abstract

Population-based cancer registries (PBCRs) are a key element for cancer control. They measure cancer incidence and trends, provide indicators for planning and evaluating cancer control activities, and undertake research. The first two PBCRs in Spain were established in Zaragoza in 1960 and Navarre in 1970, but it was from 1980 to 1995 when most of the existing registries went into operation. Today, 26.5% of the Spanish population is served by a cancer registry. All registries' quality-control indicators meet the inclusion criteria for comparability and quality of data required by the International Agency for Research on Cancer, and indeed some fulfil most of the excellence criteria for gold standard certification. After their initiation into recording accurate and complete information targeted at ascertaining cancer incidence in their catchment areas, PBCRs are progressively broadening their scope and becoming increasingly involved in collecting and analysing additional data on patient care, diagnosis, disease stage, treatment and follow-up. Spanish registries have become actively engaged in research projects, domestic and international, at a rate that has risen remarkably in the past decade. The creation of a network of Spanish cancer registries is being considered, with the aim of its becoming a key player in developing standards for cancer registration, providing training and technical assistance, undertaking quality audits and promoting the use of cancer surveillance data to reduce the burden of cancer in Spain.

Entities:  

Mesh:

Year:  2010        PMID: 20427357     DOI: 10.1093/annonc/mdq094

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  19 in total

1.  Cancer survival in adult patients in Spain. Results from nine population-based cancer registries.

Authors:  M D Chirlaque; D Salmerón; J Galceran; A Ameijide; A Mateos; A Torrella; R Jiménez; N Larrañaga; R Marcos-Gragera; E Ardanaz; M Sant; P Minicozzi; C Navarro; M J Sánchez
Journal:  Clin Transl Oncol       Date:  2017-07-17       Impact factor: 3.405

2.  Laryngeal cancer survival in Zaragoza (Spain): a population-based study.

Authors:  Dyego Leandro Bezerra de Souza; Javier Jerez Roig; María Milagros Bernal
Journal:  Clin Transl Oncol       Date:  2012-03       Impact factor: 3.405

3.  Cancer incidence in Spain, 2015.

Authors:  J Galceran; A Ameijide; M Carulla; A Mateos; J R Quirós; D Rojas; A Alemán; A Torrella; M Chico; M Vicente; J M Díaz; N Larrañaga; R Marcos-Gragera; M J Sánchez; J Perucha; P Franch; C Navarro; E Ardanaz; J Bigorra; P Rodrigo; R Peris Bonet
Journal:  Clin Transl Oncol       Date:  2017-01-16       Impact factor: 3.405

4.  Cancer in children and adolescents in Spain: incidence, treatment setting and provider specialty.

Authors:  P Berlanga; M L Vicente; A Cañete; C Alberich; V Castel
Journal:  Clin Transl Oncol       Date:  2015-06-25       Impact factor: 3.405

5.  Trends in prostate cancer survival in Spain: results from population-based cancer registries.

Authors:  Rafael Marcos-Gragera; Diego Salmerón; Isabel Izarzugaza; Eva Ardanaz; Bernat-Carles Serdà; Nerea Larrañaga; Erkuden San Román; Carmen Navarro; María-Dolores Chirlaque
Journal:  Clin Transl Oncol       Date:  2012-06       Impact factor: 3.405

6.  Incidence and survival time trends for Spanish children and adolescents with leukaemia from 1983 to 2007.

Authors:  R Marcos-Gragera; J Galceran; C Martos; A L de Munain; M Vicente-Raneda; C Navarro; J R Quirós-Garcia; M-J Sánchez; E Ardanaz; M Ramos; A Mateos; D Salmerón; S Felipe; R Peris-Bonet
Journal:  Clin Transl Oncol       Date:  2016-07-22       Impact factor: 3.405

7.  Clinical intervals and diagnostic characteristics in a cohort of prostate cancer patients in Spain: a multicentre observational study.

Authors:  Xavier Bonfill; María José Martinez-Zapata; Robin W M Vernooij; María José Sánchez; María Morales Suárez-Varela; Javier de la Cruz; José Ignacio Emparanza; Montserrat Ferrer; José Ignacio Pijoán; Juan M Ramos-Goñi; Joan Palou; Stefanie Schmidt; Víctor Abraira; Javier Zamora
Journal:  BMC Urol       Date:  2015-07-02       Impact factor: 2.264

8.  Changes in period and cohort effects on haematological cancer mortality in Spain, 1952-2006.

Authors:  Roberto Pastor-Barriuso; Gonzalo López-Abente
Journal:  BMC Cancer       Date:  2014-04-10       Impact factor: 4.430

9.  A multisource approach to improving epidemiologic estimates: application to global B-cell malignancies.

Authors:  Meghan E Mitchell; Kimberly Lowe; Jon Fryzek
Journal:  ISRN Oncol       Date:  2012-12-31

10.  Oropharyngeal Cancer Survival: A Population-Based Study of Patients Diagnosed between 1978 and 2002.

Authors:  Dyego Leandro Bezerra de Souza; María Milagros Bernal; Javier Jerez Roig; Maria Paula Curado
Journal:  ISRN Oncol       Date:  2012-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.